EO
About
EOFlow has launched EOPatch, the world’s smallest full-featured wearable, disposable insulin pump. EOPatch wearable insulin pump is smarter, better-connected, and lasts longer than the current market leader, yet costs less. The company will offer a software upgrade to enable closed-loop insulin control ('artificial pancreas' or 'automated insulin delivery') on the current system. It is also developing an all-in-one wearable disposable artificial pancreas solution, which was recently given a Breakthrough Device designation by FDA.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 116 investors are based in Seongnam, Kyonggi-do, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Seongnam, South Korea
Contact Information
Find more investors like EOFlow
Search Investors